NICE to back new Alzheimer's drugs

Draft guidance from NICE has supported the use of new drug memantine for the first time.

In the guidance, NICE advises that memantine, an NMDA-receptor antagonist, should be offered to patients with moderate Alzheimer's who are intolerant of, or have a contraindication to, AChE inhibitors. NICE said the drug should also be offered to patients with severe disease.

Previously, NICE had not recommended memantine on cost effectiveness grounds, but has reversed its decision in light of new efficacy data.

NICE also extended its recommendation for the use of three acetylcholinesterase (AChE) inhibitors – donepezil, galantamine and rivastigmine – to include mild, as well as moderate, disease.

NICE chief executive Sir Andrew Dillon said: ‘Our increased confidence in the benefits and costs associated with the use of the three drugs for treating mild and moderate stages of the disease has enabled us to make a positive recommendation for their use in mild disease.’

A consultation on the guidance will run until 28 October.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Advance decisions to refuse treatment - what GPs need to know

Advance decisions to refuse treatment - what GPs need to know

A recent case has underlined the need for GPs to communicate a patient’s known wishes...

Law changed to allow physios and paramedics to administer vaccines during pandemic

Law changed to allow physios and paramedics to administer vaccines during pandemic

A wider range of healthcare workers will be allowed to administer flu and potential...

Medicines shortages drive up GP workload as prescribing costs surge £158m

Medicines shortages drive up GP workload as prescribing costs surge £158m

Medicines shortages in England are continuing to drive up GP workload during the...

Arrhythmias - red flag symptoms

Arrhythmias - red flag symptoms

Dr Pipin Singh provides an overview of red flag symptoms in patients with arrhythmias.

How have GP practices fared under CQC inspections?

How have GP practices fared under CQC inspections?

The latest annual report from the CQC sets out ratings for all of the sectors it...

CQC flags concern over GP access despite 2m face-to-face appointments last week

CQC flags concern over GP access despite 2m face-to-face appointments last week

The CQC plans to 'follow up' concerns about access to face-to-face GP services, warning...